Negative sentiment reaches 0% here, compared with 26% across the 4352-story beat baseline for the same window. earnings accounts for 4 of the 6 tracked stories, while 1 other category carries the remainder. Their average consequence score of 5.2 runs below the beat's 6.3 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Zacks Investment Research
Negative sentiment reaches 0% here, compared with 26% across the 4352-story beat baseline for the same window. earnings accounts for 4 of the 6 tracked stories, while 1 other category carries the remainder. Their average consequence score of 5.2 runs below the beat's 6.3 for that window. Zacks Investment Research is most often covered alongside Nasdaq, which appears in 2 of these 6 stories. Across a 180-day span, the pace is roughly 0.2 stories per week. Source depth averages 2.7 original sources per story, versus 2.8 across the same-window beat baseline. This profile follows 6 Finance stories mentioning Zacks Investment Research across the period from February 18, 2026 to August 16, 2026.
Stories tracked
6
Per week
0.2
Negative
0%
Sources per story
2.7
Computed from the 6 stories linked to this entity, with beat comparisons drawn from all 4352 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Zacks Investment Research. Shared-story counts are live from our verified record — not editorial picks.
Replimune missed consensus EPS by $0.03 but held near its 52-week high at $14.97. Insider sales totaling over $650,000 were tax-related, while analyst targets now range up to $17, creating a gap between the $11.86 average target and the stock price.
Smith-Midland's latest quarterly results show a profitable small-cap with an almost 20% return on equity and very low leverage, even as the stock trades about 35% below its 52-week high. The $0.26 EPS and $23.36 million revenue figure, combined with rising institutional holdings, make it a watch item for value-oriented small-cap investors. However, the stock remains below its 50-day and 200-day moving averages, keeping the technical picture cautious.
Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102.
GigaCloud Technology CEO Lei Wu has sold 30,000 shares, marking his third major divestment in March 2026. The selling spree follows a significant change in the company's certifying accountant and a conflicting 'Strong Buy' upgrade from analysts.
urban-gro (NASDAQ: UGRO) reported a staggering quarterly loss of $9.48 per share on revenue of just $2.38 million, missing historical benchmarks significantly. The results triggered a sharp sell-off, reflecting deep investor concern over the company's viability in the struggling controlled environment agriculture sector.
The S&P 500 is struggling to maintain positive momentum in mid-February 2026, with major indices testing key resistance levels amid a shifting macroeconomic landscape. Following a transformative 2025 for digital assets, institutional focus is now pivoting toward ETF stability and the impact of broader market volatility on tech-heavy portfolios.
Zacks Investment Research is linked from 6 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.